Holobiome Company
%20.jpg)
Owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety and other mental health problems including our metabolism and the immune response, enabling patients to recover quickly from their diseases easily without any pain and suffering.
Founded Date:
2015-01-01
Last Funding Type:
Seed
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
2
Technology:
NeuroTech
Employee Number:
1-10
Industry:
Therapeutics
Funding Status:
Seed
Total Funding:
$10K